[{"address1": "11682 El Camino Real", "address2": "Suite 120", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 771 9307", "website": "https://ars-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 162, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL", "age": 58, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 3332915, "exercisedValue": 0, "unexercisedValue": 3757481}, {"maxAge": 1, "name": "Dr. Sarina  Tanimoto M.B.A., M.D.", "age": 55, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 2936973, "exercisedValue": 0, "unexercisedValue": 520353}, {"maxAge": 1, "name": "Mr. Brian T. Dorsey M.S.", "age": 55, "title": "Chief Operating Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 706970, "exercisedValue": 0, "unexercisedValue": 4750777}, {"maxAge": 1, "name": "Dr. Robert  Bell Ph.D.", "title": "Co-Founder & Chief Science Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen D. Scott CPA", "title": "Chief Financial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander A. Fitzpatrick Esq.", "age": 57, "title": "Chief Legal Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 677145, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Relovsky", "title": "Senior Vice President of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lynda  Harris", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin  Chakma", "age": 34, "title": "Chief Business Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harris  Kaplan M.B.A.", "age": 72, "title": "Executive Vice President of Commercial Strategy", "yearBorn": 1952, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.62, "open": 8.62, "dayLow": 8.4517, "dayHigh": 8.98, "regularMarketPreviousClose": 8.62, "regularMarketOpen": 8.62, "regularMarketDayLow": 8.4517, "regularMarketDayHigh": 8.98, "payoutRatio": 0.0, "beta": 0.841, "forwardPE": -11.789474, "volume": 2076733, "regularMarketVolume": 2076733, "averageVolume": 2494142, "averageVolume10days": 1617600, "averageDailyVolume10Day": 1617600, "bid": 6.43, "ask": 10.93, "bidSize": 2, "askSize": 2, "marketCap": 885483968, "fiftyTwoWeekLow": 8.4517, "fiftyTwoWeekHigh": 18.9, "allTimeHigh": 63.41, "allTimeLow": 2.55, "priceToSalesTrailing12Months": 7.882249, "fiftyDayAverage": 10.4464, "twoHundredDayAverage": 13.326525, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 718973952, "profitMargins": -0.42743, "floatShares": 52091362, "sharesOutstanding": 98826337, "sharesShort": 18964276, "sharesShortPriorMonth": 21583515, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.1919, "heldPercentInsiders": 0.1683, "heldPercentInstitutions": 0.86158997, "shortRatio": 7.21, "shortPercentOfFloat": 0.3127, "impliedSharesOutstanding": 98826337, "bookValue": 1.949, "priceToBook": 4.5972295, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -48017000, "trailingEps": -0.48, "forwardEps": -0.76, "enterpriseToRevenue": 6.4, "enterpriseToEbitda": -12.241, "52WeekChange": -0.41052634, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 8.96, "targetHighPrice": 40.0, "targetLowPrice": 25.0, "targetMeanPrice": 31.33333, "targetMedianPrice": 31.0, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 240130000, "totalCashPerShare": 2.43, "ebitda": -58733000, "totalDebt": 73620000, "quickRatio": 5.838, "currentRatio": 6.172, "totalRevenue": 112339000, "debtToEquity": 38.28, "revenuePerShare": 1.15, "returnOnAssets": -0.13854, "returnOnEquity": -0.23562999, "grossProfits": 90847000, "freeCashflow": -26907750, "operatingCashflow": -52797000, "revenueGrowth": 30.434, "grossMargins": 0.80869, "ebitdaMargins": -0.52282, "operatingMargins": -3.0294602, "financialCurrency": "USD", "symbol": "SPRY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "ARS Pharmaceuticals, Inc.", "longName": "ARS Pharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1761955064, "regularMarketTime": 1761940800, "exchange": "NGM", "messageBoardId": "finmb_585213447", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": 3.94432, "regularMarketPrice": 8.96, "postMarketChangePercent": -0.44642815, "postMarketPrice": 8.92, "postMarketChange": -0.03999996, "regularMarketChange": 0.34, "regularMarketDayRange": "8.4517 - 8.98", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2494142, "fiftyTwoWeekLowChange": 0.5082998, "fiftyTwoWeekLowChangePercent": 0.060141724, "fiftyTwoWeekRange": "8.4517 - 18.9", "fiftyTwoWeekHighChange": -9.94, "fiftyTwoWeekHighChangePercent": -0.52592593, "fiftyTwoWeekChangePercent": -41.052635, "earningsTimestamp": 1755057600, "earningsTimestampStart": 1762950600, "earningsTimestampEnd": 1762950600, "earningsCallTimestampStart": 1755088200, "earningsCallTimestampEnd": 1755088200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.48, "epsForward": -0.76, "epsCurrentYear": -1.694, "priceEpsCurrentYear": -5.289256, "fiftyDayAverageChange": -1.4863997, "fiftyDayAverageChangePercent": -0.14228822, "twoHundredDayAverageChange": -4.3665247, "twoHundredDayAverageChangePercent": -0.32765666, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Silverback Therapeutics, Inc.", "nameChangeDate": "2025-10-31", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607092200000, "displayName": "ARS Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]